These findings are in line with those in the previously published COSMOS-Mind trial. That study found statistically significant improvement on global cognition in participants who took a multivitamin over the course of the long-term clinical trial.
Council for Responsible Nutrition (CRN) Senior Vice President, International and Scientific Affairs, Jim Griffths, Ph.D., was among the COSMOS-Mind trial participants. “CRN has always recognized the importance of multivitamins is to fill nutrient gaps and to ensure the public gets the recommended levels of nutrients essential to everyday life," Dr. Griffths said. "This study is another exciting example of the ever-growing body of evidence demonstrating the benefits of multivitamins on both physical health and cognitive function.”
“These results are certainly important, as there is an urgent need to identify strategies to preserve cognitive function and reduce the burden of dementia on families and society. This clinical trial reinforces the important role supplements play in helping adults meet their nutrient needs, which is a critical part of healthy aging for the mind and body.
“Last year, participants in CHPA’s Regulatory, Scientific and Quality Conference had the opportunity to hear directly from Mark Espeland, Ph.D., Principal Investigator on the 2022 COSMOS-Mind trial results, and we are excited to see this additional study published. Scientific evidence grows in increments, and this study is an important component in strengthening the beneficial role of safe, accessible, and affordable dietary supplements that can be used to optimize health through self-care.”